Recursion Pharmaceuticals shows high cash burn, limited efficacy data, and unproven platform validation. Check out why RXRX ...

Amidst the AI boom transforming various sectors, Recursion Pharmaceuticals (NASDAQ: RXRX), a previously beaten-down ...

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...

The Council today formally adopted the soil monitoring directive, establishing the first-ever EU-wide framework for assessing and monitoring soils, with the overarching aspirational goal of achieving ...

On September 1st, the author and statistician Nate Silver wrote a post on X diagnosing a new condition: “Blueskyism,” so named for the decentralized social network that has emerged as a competitor to ...

Jocelyn Solis-Moreira is a freelance health and science journalist based in New York. There’s nothing like shutting the bathroom door, maybe even locking it and hiding away from one’s family, even ...

The famous quote from the movie Jaws is "You're gonna need a bigger boat." This line is spoken by Chief Martin Brody (played by Roy Scheider) to Quint (played by Robert Shaw) during the film. The line ...

Debate over the song of the summer rages on, but if there were a contest for a word of the summer, one front-runner would surely be the onomatopoeic clanker. In recent weeks, clanker has risen to ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...